Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice of extraordinary general meeting in ChromoGenics

Shareholders in ChromoGenics AB (publ) are hereby convened to the extraordinary general meeting on Friday 15 December 2017, at 13:00 at Advokatfirman Lindahl’s office on Vaksalagatan 10, Uppsala.  NOTICE OF EXTRAORDINARY GENERAL MEETING IN CHROMOGENICS AB (PUBL) The shareholders in ChromoGenics AB (publ) reg. no. 556630-1809 (the “Company”) are hereby convened to the extraordinary general meeting on Friday 15 December 2017, at 13:00 at Advokatfirman Lindahl’s office on Vaksalagatan 10, Uppsala. Notification etc. Shareholders who wish to participate at the extraordinary

ChromoGenics targets an offensive market expansion and announces a rights issue with pre-emption rights of ca 40 MSEK

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, NEW ZEALAND, SOUTH AFRICA, CANADA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.Summary · The board of directors of ChromoGenics AB (publ), (“ChromoGenics”, the “Company”) has resolved to issue new shares and warrants (units) (the “Rights Issue”), subject to approval by an extraordinary general meeting on 15 December 2017. Upon full

IK expands its small cap strategy to the Benelux region - Hires Sander van Vreumingen as Benelux Small Cap partner

IK Investment Partners (“IK”), a leading Pan-European private equity firm, today announces that Sander van Vreumingen has joined as a Partner responsible for IK’s Benelux Small Cap team.IK has been present in the Benelux region since 1995 and has invested over €1bn into thirteen successful investments during this time. Within the mid cap space, IK has been one of the most active regional players with notable transactions including Vemedia, the market leader of OTC drugs, Magotteaux, the leading manufacturer of cast wear parts for the cement and mining industries and fund administrator

Stillfront Group AB: Nida Harb 3: Empire of Steel featured in App Store

PRESS RELEASE Nov 17, 2017  Stillfront's studio Babil Games launch of Nida Harb 3: Empire of Steel continues with a featuring on App Store.Babil Games, a studio in Stillfront Group, today launches Nida Harb 3: Empire of Steel on iOS. This is the third instalment of the highly successful "Nida Harb" franchise. Nida Harb 3: Empire of Steel is an engaging mobile MMO-RTS (Massively multiplayer online real-time strategy game). As its predecessors, the game is set with a modern warfare theme, where players are given their own command of a military base to build and train massive armies in

Aker Solutions to Provide Umbilicals for Three Offshore Norway Field Developments

November 17, 2017 - Aker Solutions won a contract to provide umbilicals for the Statoil-operated Johan Sverdrup, Utgard and Bauge developments offshore Norway. The order entails delivery of more than 40 kilometers in total of subsea umbilicals. It will be booked in the fourth quarter. "By combining the delivery for three separate projects into one order, we are able to boost efficiency and reduce costs for the customer," said Luis Araujo, Aker Solutions' chief executive officer. "We look forward to working with Statoil on these important oil and gas developments." Manufacturing

Lactobacillus reuteri reduced bone loss in older women

A randomized, double-blind, placebo-controlled study in 90 older women showed that supplementation of the probiotic strain Lactobacillus reuteri ATCC PTA 6475 decreased bone loss compared to placebo.Lactobacillus reuteri ATCC PTA 6475 is a naturally occurring bacteria in the gastrointestinal tract of humans and has been shown to have beneficial effects on bone in animals. In a randomized controlled trial conducted at the University of Gothenburg, 75 to 80-year-old women with low bone density received supplementation of Lactobacillus reuteri ATCC PTA 6475 or placebo for one year. In the

Hansa Medical's Nomination Committee for the AGM 2018 appointed

In accordance with the decision of the Annual General Meeting on May 23, 2017, a Nomination Committee for the Hansa Medical AGM 2018 has been formed. Based on the list of shareholders as of 31 August 2017, the three largest shareholders have been contacted and invited to each appoint a representative to the Nomination Committee. The Nomination Committee consists of Erika KjellbergEriksson representing Nexttobe AB, Max Mitteregger representing Gladiator and Sven Sandberg representing Thomas Olausson. The Nomination Committee also includes the chairman of the board, Birgit Stattin Norinder, as

Internationella Engelska Skolan 2017/2018 Interim Report - (1 July - 30 September 2017)

Progress of operations in the quarter (July-September) · Four new schools opened in August—IES Helsingborg, IES Landskrona, IES Södertälje and IES Årsta—with 55 classes and some 1,600 students. · The number of students in the Swedish operation at the end of the quarter was 23,911 (21,463), an 11.4% increase on the corresponding point of the previous year. · There were around 154,000 registrations on waiting lists at the end of the quarter, an increase of some 32,000 registrations on the corresponding point of the previous year. · Total operating income increased by 18.5% year

Notice to attend the Extraordinary General Meeting of DDM Holding AG

It is our pleasure to invite all shareholders of DDM Holding AG, Baar (the “Company”), to the extraordinary general meeting (the “EGM”) which will take place on Monday, 18 December 2017 at 2:30 pm CET at the premises of Parkhotel Zug, Industriestrasse 14, 6300 Zug, Switzerland. The doors will open at 2:00 pm CET.A.  Agenda and Proposal 1.   Election of a new Board Member The board of directors of the Company (the Board of Directors) proposes that Mr. Mikael Nachemson be elected as a new member of the Board of Directors for a term of office expiring upon completion of the next annual

Resurs Bank examines the possibility to issue bonds within existing MTN-programme

Resurs Bank AB (Publ), a subsidiary to Resurs Holding, has mandated Nordea and Swedbank for an expected SEK 500m 3 year senior unsecured transaction, under the issuers SEK 5bn MTN Programme. The transaction will follow after a fixed income investor presentation (breakfast) on 28 November in Stockholm, subject to market conditions.  For additional information:Peter Rosén, CFO & Head of IR, peter.rosen@resurs.se  +46 736 56 49 34Sofie Tarring, IR-Officer, sofie.tarring@resurs.se +46 736 44 33 95   About Resurs Holding:Resurs Holding (Resurs), which operates through the

Serneke to build 160 rental apartments in Årsta

Serneke has today signed a turnkey contract with Stockholmshem regarding the construction of 160 homes in Årsta. The order is valued at approximately SEK 330 million.The project, located within the Sävlången 2 and Idlången 3 properties, is part of the so-called Årstastråket area, where the City of Stockholm plans to create some 3,000 new homes for 7,500 inhabitants over a period of at least ten years in a central and attractive location, with good access to public transport, recreation opportunities and services. In addition to housing, the contract includes a preschool with four

Resurs Bank examines the possibility to issue bonds within existing MTN-programme

Resurs Bank AB (Publ) has mandated Nordea and Swedbank for an expected SEK 500m 3 year senior unsecured transaction, under the issuers SEK 5bn MTN Programme. The transaction will follow after a fixed income investor presentation (breakfast) on 28 November in Stockholm, subject to market conditions. For additional information:Peter Rosén, CFO & Head of IR, peter.rosen@resurs.se  +46 736 56 49 34Sofie Tarring, IR-Officer, sofie.tarring@resurs.se +46 736 44 33 95    About Resurs Bank:Resurs was founded in 1977 and is one of the fastest-growing niche banks in the Nordic region.

InDex Pharmaceuticals Holding AB (publ) interim report January – September 2017

Strengthened patent protection for cobitolimodPeriod July – September 2017 ·  Revenues amounted to SEK 0.0 (0.0) million ·  Operating result amounted to SEK –13.3 (–6.6) million ·  Result after tax amounted to SEK –13.1 (–7.4) million, corresponding to SEK –0.21 per share (–0.25) before and after dilution ·  Cash flow from operating activities amounted to SEK –16.6 (–7.5) million  Period January – September 2017 ·  Revenues amounted to SEK 0.1 (0.1) million ·  Operating result amounted to SEK –50.7 (–23.2) million ·  Result after tax amounted to SEK –50.4 (–24.9)

Prestigious award to Polygon Norway

Polygon AS in Norway has been honored with the “Service Achievement of the Year 2017” award by NHO Service (The Confederation of Norwegian Enterprise in the Service Sector). The award was recently presented during NHO Service`s annual conference and was accepted by a very proud Kai Andersen, Country President for Polygon Norway.“It makes me very proud of being part of such an organisation as Polygon Norway. We are thrilled to get this award and it shows that all our work we have done has paid off”, says Kai Andersen, Country President at Polygon Norway. The jury’s motivation:“Polygon

Jon Shafer moves on from Paradox Interactive

In May this year Paradox Interactive announced it had hired award winning game developer Jon Shafer, to start a new project. Today Paradox and Shafer announced that they have decided to part ways due to creative differences.  "Jon is an ambitious person with a lot of drive and passion and he has led some good discussions in our teams over the past few months", said Mattias Lilja - Executive Vice President of Studios at Paradox Interactive. "However, during the course of these discussions, it has become clear that we want different things creatively and we have therefore taken the mutual

TECHSTEP ASA: Q3 2017 RESULTS

Highlights · Techstep has continued to execute its growth strategy by acquiring two additional companies, developing its “Mobile as a Service” offering, growing its end user base and solutions sales · Q3 2017 revenues of NOK 180.8 million (NOK 132.7 million) ; increase reflecting acquisitions made in the period, as well as 40% organic growth in solutions revenue · Adjusted EBITDA of NOK 9.8 million (NOK 4.1 million) and EBITDA margin of 5.4% (3.1%) ; reflects positive development in solutions sales, partly offset by growth investments · Surpassed 600,000 end users across

Viking Line: Business Review for the period January - September 2017

Viking Line Abp           BUSINESS REVIEW            17.11.2017, 9.00 AMBUSINESS REVIEW FOR THE PERIOD JANUARY–SEPTEMBER 2017 Consolidated sales of the Viking Line Group for the period January 1–September 30, 2017 rose to 399.6 million euros (EUR 397.3 M for January 1–September 30, 2016). Other operating revenue amounted to EUR 1.3 M (2.0). Operating income totalled EUR 6.3 M (14.8). Net financial items totalled EUR -1.7 M (-3.2). Consolidated income before taxes amounted to EUR 4.6 M (11.6). Income after taxes totalled EUR 3.8 M (9.7). Competition in Viking Line's service area

Hiddn Solutions ASA - Mandatory notification of trade

Reference is made to the announcement made on 16 November 2017 by Hiddn Solutions ASA (the "Company") in connection with a successfully private placement of NOK 7,500,000 million in new shares. Dallas Asset Management AS, a company controlled by Jan Opsahl, board member in the Company, has been allocated 1,000,000 shares in the Company. Following the completion of the private placement, Dallas Asset Management AS will hold 3,200,000 shares (4.29%) in the Company. Wollebekkgruppen AS, a company 50 % owned by Carl Espen Wollebekk, CEO, has been allocated 100,000 shares in the Company.

Planmeca CALM™ receives Innovation 2017 honorary mention

The dental industry Innovation award will once again be handed out at this month’s Finnish Dental Congress and Exhibition  in Helsinki, Finland. The award and accompanying honorary mentions are given to companies or associations which have developed a product, service or technology that has significantly improved treatment, patient safety or the working conditions of the dentist. The Planmeca CALM™ algorithm solves the challenge of movement artefacts in CBCT imaging The new Planmeca CALM™ algorithm has received the Innovation 2017

Ambea interim report January-September 2017

CEO comment: ”In the third quarter, we continued to see positive results from our strategy, which is to grow the number of our Own Management units both by opening new residential care units and through acquisitions. During the quarter, we opened two new LSS residential care units in Sweden one new unit in Norway, and completed one acquisition in each market. Our organic growth in Norway is proceeding well, but the weak tender market in Sweden and the supported living units that were closed down – and for which we are still awaiting permits – are posing a challenge. Net sales for the

Ambea repurchases own shares

The Board of Ambea AB (publ) has resolved to initiate a share buyback program for a total of 62,277 shares until May 22, 2018.Repurchased shares will be saved to be used under Ambea’s share savings plan. The buyback program will be managed by a securities company or credit institution that makes its trading decisions regarding Ambea’s shares independently of, and without influence by, Ambea with regard to the timing of the repurchases. The buyback program shall meet the following terms: 1. Repurchases of shares are to be made on Nasdaq Stockholm and in accordance with Nasdaq

Multiconsult ASA – Repurchase of own shares

On 16 November 2017, Multiconsult ASA ("Multiconsult") purchased 1 764 of its own shares at an average price of NOK 75.94 per share. The shares were purchased in accordance with the Company's share repurchase programme as announced on 22 September 2017. The shares were acquired on Oslo Børs.Following this transaction Multiconsult holds 426 726 of its own shares.  For further information, please contact: Investor relations:      Mirza Koristovic, Head of Investor Relations      Phone: +47 93 87 05 25      E-mail: ir@multiconsult.no Media:      Gaute Christensen, VP

BerGenBio ASA: Results for the Third Quarter 2017

Bergen, Norway, 17 November 2017 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective Axl kinase inhibitors for multiple cancer indications, announces its results for the third quarter 2017. A presentation of the results by the Company’s senior management team will take place today at 9.00 am CET in Oslo – details below.Richard Godfrey, Chief Executive Officer of BerGenBio, commented: “We are very pleased with the progress the company has made during Q3 2017. Our broad clinical development programme of Phase 2 trials with BGB324, our

THQ Nordic acquires Biomutant® developer Experiment 101

THQ Nordic is today announcing that it has acquired the shares of Experiment 101 AB, a Swedish independent game developer, currently developing the critically acclaimed game Biomutant. The acquisition includes the development studio and all intellectual property rights to Biomutant.Biomutant is an open world, post-apocalyptic kung-fu fable action role-playing game. The game was first announced at Gamescom in August 2017, receiving strong reception with fans and the gaming media. The total consideration paid for all shares is SEK 75.3 million paid to the sellers Goodbye Kansas and Stefan

There are no items matching the current filter
There are no more items matching the current filter
Back to top